ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 156

Unexpectedly High Prevalence  of Immunoglobulin Deficiency in Fibromyalgia – II

Xavier J. Caro1,2 and Earl F. Winter2, 1Northridge Hospital Medical Center, Northridge, CA, 2Southern California Fibromyalgia Research and Treatment Center, Northridge, CA

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Fibromyalgia and immune deficiency

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 5, 2017

Title: Fibromyalgia, Soft Tissue Disorders, Regional and Specific Clinical Pain Syndromes Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

­­­ Background/Purpose: We have recently reported that 70% of an unselected FM cohort (n = 107) had subtle laboratory findings of Primary Immune Deficiency (PID), usually consisting of one or more immunoglobulin subclass deficiencies (Arthritis Rheum 2014;55(11): S905). To better understand this finding we surveyed a second cohort of FM subjects for laboratory evidence of PID, and – additionally – any clinical evidence of recurrent infections. Our results are reported here.

Methods: We retrospectively reviewed serum Ig concentration values on all FM subjects seen between December 2013 and May 2017 in an outpatient, rheumatology office setting. No other diagnosis precluded inclusion in the study unless it was likely that it might predispose to Ig deficiency. A total of 81 consecutive FM subjects, meeting 2010 ACR criteria, were screened; 4 were excluded (i.e., alcohol abuse; prior cancer chemotherapy; age < 18 yrs.). Data on 77 remaining FM subjects were reviewed; 43 of these had coincident RA (26 % seropositive). Ig deficiency was defined as an Ig value below the lower limits of normal (LLN) suggested by PaulÕs Fundamental Immunology ( ); all deficient specimens were tested in duplicate. Ig abnormalities were confirmed by repeat analysis 6 – 9 weeks later. We also reviewed the prevalence of deficient or low mannose binding lectin in these subjects (deficient < 50 ng/ml; low < 500 ng/ml). In an attempt to further ascertain the role of Ig deficiency in FM we also studied the prevalence of any Ig level > LLN but within the lower most quartile of normal values (range / 4). We also collected data regarding a ÒLifetime History of InfectionsÓ on all FM subjects and 26 ÒApparently HealthyÓ aged-matched, community volunteers (± 5 years).

Results: Our findings are listed below:

Serum Ig Deficiency in 77 FM Subjects Compared to Literature Based Controls

Immunoglobulin

Fibromyalgia Subjects

No. with

Ig deficiency

No. with- out Ig deficiency

Prevalence of FM Ig Deficiency

Estimated

Normal Prevalence

P-value

(2-tailed)

IgG Subclass 1

27

50

35%

1/1200

<0.0001

IgG Subclass 2

12

65

16%

1/1200

<0.0001

IgG Subclass 3

37

40

48%

1/1200

<0.0001

IgG Subclass 4

34

43

44%

1/1200

<0.0001

IgA Subclass 1

20

57

26%

1/500

<0.0001

IgA Subclass 2

11

66

14%

3/100

0.002

IgM

1

76

1%

3/100

NS

IgE

11

66

14%

2.5/100

0.002

Any Ig

64

13

83%

1/1200

<0.0001

Schroeder HW, et al: Immunoglobulin Structure and Function. In Fundamental Immunology. 7th Ed.

Ed: Paul, WE. Lippincott, New York 2013. Analysis was by Chi-square test.

Of 71 FM subjects in whom Mannose Binding Lectin (MBL) was measured 18 (23 %) had levels <500 ng/ml, and 12 (16%) had levels <50 ng/ml. The prevalence any Ig in FM subjects being within our estimate of PaulÕs ( ) lowest quartile for normal Ig levels ranged from 40% to 74%. There was no significant difference in the prevalence of Ig deficiency in FM subjects with concomitant RA compared to those without RA. A history of recurrent sinus infections was not significantly more common in our FM subjects compared to controls, but a history of recurrent serious, non-sinus infections was more prevalent for FM (P(1) = 0.009), and FM + RA (P(1) = < 0.0001).

Conclusion: Our study shows that clinically significant Ig deficiency, particularly IgG subclass deficiency, is a common accompaniment to FM. It also strengthens the argument that FM may be a disorder associated with immune dysregulation. The precise mechanism of this interaction remains unclear, but deserves further investigation.


Disclosure: X. J. Caro, None; E. F. Winter, None.

To cite this abstract in AMA style:

Caro XJ, Winter EF. Unexpectedly High Prevalence  of Immunoglobulin Deficiency in Fibromyalgia – II [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/unexpectedly-high-prevalence-of-immunoglobulin-deficiency-in-fibromyalgia-ii/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/unexpectedly-high-prevalence-of-immunoglobulin-deficiency-in-fibromyalgia-ii/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology